We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Sabre Insurance Group Plc | SBRE | London | Ordinary Share |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
162.40 | 162.40 | 168.00 | 159.00 |
Industry Sector |
---|
NONLIFE INSURANCE |
Announcement Date | Type | Currency | Dividend Amount | Ex Date | Record Date | Payment Date |
---|---|---|---|---|---|---|
03/08/2023 | Interim | GBP | 0.009 | 17/08/2023 | 18/08/2023 | 20/09/2023 |
14/03/2023 | Special | GBP | 0.017 | 20/04/2023 | 21/04/2023 | 01/06/2023 |
22/03/2022 | Interim | GBP | 0.028 | 18/08/2022 | 19/08/2022 | 22/09/2022 |
22/03/2022 | Special | GBP | 0.046 | 28/04/2022 | 29/04/2022 | 01/06/2022 |
22/03/2022 | Final | GBP | 0.047 | 28/04/2022 | 29/04/2022 | 01/06/2022 |
16/03/2021 | Interim | GBP | 0.037 | 19/08/2021 | 20/08/2021 | 16/09/2021 |
16/03/2021 | Final | GBP | 0.068 | 22/04/2021 | 23/04/2021 | 20/05/2021 |
28/07/2020 | Special | GBP | 0.052 | 06/08/2020 | 07/08/2020 | 28/08/2020 |
07/04/2020 | Special | GBP | 0.043 | 06/08/2020 | 07/08/2020 | 28/08/2020 |
07/04/2020 | Final | GBP | 0.081 | 23/04/2020 | 24/04/2020 | 28/05/2020 |
28/03/2019 | Interim | GBP | 0.047 | 22/08/2019 | 23/08/2019 | 19/09/2019 |
28/03/2019 | Final | GBP | 0.068 | 25/04/2019 | 26/04/2019 | 30/05/2019 |
28/03/2019 | Special | GBP | 0.06 | 25/04/2019 | 26/04/2019 | 30/05/2019 |
Top Posts |
---|
Posted at 02/4/2023 08:39 by wba1 Hopan; I think that either SBRE is overvalued or DLG undervalued. On balance I lean to the latter but that is just my view. I am convinced both valuations cannot be right. My main concern with SBRE is the likely continuing impact of the motorcycle and taxi accounts as they build to a full effect on profit through the earnings pattern. They will be a much bigger % of earned premium in 2023 than 2022 and I do not believe SBRE can expect them to produce a loss ratio anywhere near that of the traditional Sabre business. SBRE seems to be in transition to a COR much nearer to the market performance than its past 20 point advantage simply because of its pursuit of new business sources. |
Posted at 31/3/2023 23:06 by hopan Hi Wba1, thanks for the analysis. Just to clarify, you think SBRE is overvalued compared to the DLG, right?I appreciate SBRE management on expecting the claim inflation. Well before the others. Good decision. And they ended up almost flat for 2022. |
Posted at 30/10/2022 11:27 by jonnybig The first sign of management incompetence tells you to avoid, and I'm afraid that's what the sbre management is ..... incompetent. |
Posted at 23/10/2022 06:16 by spectoacc Thanks @wba1. Not (& never have been) a SBRE holder but appreciate your insight.Fwiw have fully sold out of Direct Line (which is what brought me to this thread) but based more on economic outlook than the insurance market. We're evidently going to hell in a handcart atm, with retrenching consumer, retrenching govnt, tightening BoE. |
Posted at 02/8/2022 08:29 by thebutler It does make you wonder if the management know what they're doing ....... some of the directors bought following last year's fall (round about 190p if I remember rightly). I had SBRE on my watchlist as it seemed to be progressing OK with a smallish market cap which might have attracted buyout interest, but having said that the P/E still seemed a tad high compared with its peers.But what ultimately stopped me taking the plunge was a well informed post by yourself, wba1, so I thankyou for that. Those results the other week were awful, and as such I have removed SBRE from my watchlist. |
Posted at 15/7/2022 04:44 by jubberjim Anyone have any idea what dividend if any is likely to be forthcomingThought the drop was a trifle overdone but where do you pick the nadir Did pick up a few DLG average 210 but as stated elsewhere up to my limit on Aviva Lgen MNG and Phnx will have to sell something to buy anymore Will be watching banks namely Barclays and Lloyds as results will be forthcoming shortly No share or sector is not going to come under pressure and the paucity of the liquidity and willingness to deal will exaggerate any downward moves Stout hearts and undergarments needed over coming days. Just hope the dividends deliver else we are all in trouble. Good luck all |
Posted at 14/7/2022 14:20 by wba1 Like EI I have just taken a few DLG at 206. My thinking is that the rating is pretty low and the risk is more spread. Motor (and liability) is long tail business meaning large prior year reserves. Property is short tail, meaning little prior year reserves. SBRE were fully exposed to any reserve issues as a pure motor play. DLG have significant short tail business (property and some other including sme and pet - plus Green Flag) which dilutes the reserve exposure even if SBRE were not just caught out by setting margins inadequately before, as I suspect. I am not sure where the market is going on insurers but a 10% yield, even if it sees some cut, is hard to resist. Other insurers are even less exposed with the likes of Aviva having long tail general insurance as only a small part of the group business.On US insurers; I used to work for the UK subsidiary of one and went over many times. The comparison is almost impossible to make with regulation at state level, less sophisticated pricing models (often driven by local regulators and a strong distribution focus. Any assessment only works based on an in depth dive into each company. |
Posted at 14/7/2022 07:19 by spectoacc Well, you've got your "..Below 150.." @wba1! Have just read your posts on here back to January and although you say it's caught you out by being much worse than expected, hats off to you - you were exactly right about SBRE's change in business model.Assume that change came about due to shrinking growth opportunities/shrink Not a holder of SBRE - but do have a few DLG tucked away, so am understandably nervous. |
Posted at 26/4/2022 07:44 by topvest I've recently taken a small opening position here. Prospects appear to be improving. One of the few shares in an uptrend. Disciplined underwriting record. 6.5% dividend yield. |
Posted at 28/3/2022 13:57 by km18 Sabre Insurance is engaged in the writing of general insurance for motor vehicles and motorcycles in the United Kingdom. Currently, the firm is providing its products through a network of insurance brokers, as well as its own direct brands. As a result, Sabre Insurance Group expanded its sources of income, enabling the firm to derive an attractive EV/EBITDA of 14.24, which in turn led to a robust profit before tax of £37,199. The firm also derived a concise P/FCF of 17x, signifying that operating, investing and financing activities were funded effectively, enabling the firm to achieve organic growth and thereby a relatively high EPS growth of 15.9%. Consequently, it implied that Sabre Insurance Group managed to optimise earnings while paying out attractive dividends to investors. This supporting evidence suggests that the group has adopted a conservative dividend payout policy, where current shareholders are paid fairly and on time, illustrated by the dividend yield of 6.05%. From a valuation perspective, Sabre Insurance boosted its P/S ratio to 3.71x, as the firm is suppling more insurance products with different brokers. Given that the group is trading at a P/E ratio of 15.8x, the security is undervalued with respect to the insurance services industry, thus the stock is expected to surge in value, illustrated by the P/B ratio of 2.24x.Keep up to date with WealthOracle AM |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: +44 (0) 203 8794 460 | support@advfn.com |
ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
ADVFN France ADVFN US ADVFN Korea |